About T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta is a rare disease catalogued by Orphanet (ORPHA:169160). It is associated with the CD3D, CD3E, CD247 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta trials.
Search ClinicalTrials.gov for "T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta" or filter by Orphanet code ORPHA:169160 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta. Updated daily.